Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Most therapeutic approaches for NF1 have focused on blocking a specific cell signaling pathway, called Ras/MAPK, which is hyperactive in cells that have lost NF1 function due to gene mutation. This ...

The pharmaceutical industry has long operated on a one-size-fits-all model, developing drugs primarily tested on, and thus best suited for, people of European descent. This approach ignores — and ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Most startups do not have internal access to designated animal research facilities. As a result, pharmaceutical and biotech founding researchers are faced with the dilemma of finding vivarium space ...

MARTIGNY, Switzerland & DIJON, France--(BUSINESS WIRE)--Debiopharm Research & Manufacturing S.A. (Debiopharm, www.debiopharm.com), a Swiss-based global biopharmaceutical company aiming to cure cancer ...

Preclinical imaging is rapidly becoming a standard technology for drug discovery and development. This adoption has been driven by the increasing pressure on pharmaceutical companies to identify ways ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that preclinical data on ARO-INHBE, an investigational RNAi-based medicine for the treatment of ...